Satellos Bioscience Inc. — Form D

Satellos Bioscience Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-03. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Rima Al-awarDirectorToronto, A6
Franklin D BergerDirectorToronto, A6
Brian BloomDirectorToronto, A6
Stephanie D BrownDirectorToronto, A6
Frank GleesonDirectorToronto, A6
Bill JaroszDirectorToronto, A6
Geoff MacKayDirectorToronto, A6
William McVicarDirectorToronto, A6
Adam MostafaDirectorToronto, A6
Michael Robert CrossExecutive OfficerToronto, A6
Frank GleesonExecutive OfficerToronto, A6
Philip D LambertExecutive OfficerToronto, A6
Michael RudnickiExecutive OfficerToronto, A6
Courtney D WellsExecutive OfficerToronto, A6
Elizabeth WilliamsExecutive OfficerCroton on Hudson, NY
Frank GleesonPromoterToronto, A6
Michael RudnickiPromoterToronto, A6
Michael LiggettDirectorVancouver, A1
Michael LiggettExecutive OfficerVancouver, A1
J. Robert HallExecutive OfficerToronto, A6
Warren WhiteheadExecutive OfficerToronto, A6
SUSAN KOPPYDirectorVANCOUVER, A1
ANDREW RAEDirectorVANCOUVER, A1
ANDREW RAEExecutive OfficerVANCOUVER, A1
WILLIAM JAROSZDirectorVANCOUVER, A1

Other filings by this issuer (9)

FiledFormOfferingSold
2023-05-25D$33.3M$33.3M
2022-09-27D$2.1M$99K
2019-09-10D$2.5M$188K
2019-03-08D$972K$152K
2014-02-05D$7.9M$2.0M
2013-11-21D/A$126K$126K
2011-11-15D$50K$50K
2009-12-01D/A$3.3M$3.3M
2009-11-06D$2.7M$2.7M

More